Ratmir Derda

Prof. Ratmir Derda


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RDRatmir Derda
Ratmir Derda
STSindy K. Y. Tang
Sindy K. Y. Tang
ALAnna Laromaine
Anna Laromaine
BMBobak Mosadegh
Bobak Mosadegh
EHEstrella Hong
Estrella Hong
GWGeorge M. Whitesides
George M. Whitesides
In vitro 3D culture is an important model for tissues in vivo. Cells in different locations of 3D tissues are physiologically different, because they are exposed to different concentrations of oxygen, nutrients, and signaling molecules, and to other environmental factors (temperature, mechanical stress, etc). The majority of high-throughput assays based on 3D cultures, however, can only detect the average behavior of cells in the whole 3D construct. Isolation of cells from specific regions of 3D cultures is possible, but relies on low-throughput techniques such as tissue sectioning and micromanipulation. Based on a procedure reported previously (“cells-in-gels-in-paper” or CiGiP), this paper describes a simple method for culture of arrays of thin planar sections of tissues, either alone or stacked to create more complex 3D tissue structures. This procedure starts with sheets of paper patterned with hydrophobic regions that form 96 hydrophilic zones. Serial spotting of cells suspended in extracellular matrix (ECM) gel onto the patterned paper creates an array of 200 micron-thick slabs of ECM gel (supported mechanically by cellulose fibers) containing cells. Stacking the sheets with zones aligned on top of one another assembles 96 3D multilayer constructs. De-stacking the layers of the 3D culture, by peeling apart the sheets of paper, “sections” all 96 cultures at once. It is, thus, simple to isolate 200-micron-thick cell-containing slabs from each 3D culture in the 96-zone array. Because the 3D cultures are assembled from multiple layers, the number of cells plated initially in each layer determines the spatial distribution of cells in the stacked 3D cultures. This capability made it possible to compare the growth of 3D tumor models of different spatial composition, and to examine the migration of cells in these structures.

21 February 2011 in Molecules
Verified
Journal Article
Open access
PDF file
RDRatmir Derda
Ratmir Derda
STSindy K.Y. Tang
Sindy K.Y. Tang
SLS. Cory Li
S. Cory Li
SNSimon Ng
Simon Ng
WMWadim Matochko
Wadim Matochko
MJMohammad R. Jafari
Mohammad R. Jafari
The amplification of phage-displayed libraries is an essential step in the selection of ligands from these libraries. The amplification of libraries, however, decreases their diversity and limits the number of binding clones that a screen can identify. While this decrease might not be a problem for screens against targets with a single binding site (e.g., proteins), it can severely hinder the identification of useful ligands for targets with multiple binding sites (e.g., cells). This review aims to characterize the loss in the diversity of libraries during amplification. Analysis of the peptide sequences obtained in several hundred screens of peptide libraries shows explicitly that there is a significant decrease in library diversity that occurs during the amplification of phage in bacteria. This loss during amplification is not unique to specific libraries: it is observed in many of the phage display systems we have surveyed. The loss in library diversity originates from competition among phage clones in a common pool of bacteria. Based on growth data from the literature and models of phage growth, we show that this competition originates from growth rate differences of only a few percent for different phage clones. We summarize the findings using a simple two-dimensional “phage phase diagram”, which describes how the collapse of libraries, due to panning and amplification, leads to the identification of only a subset of the available ligands. This review also highlights techniques that allow elimination of amplification-induced losses of diversity, and how these techniques can be used to improve phage-display selection and enable the identification of novel ligands.

12 July 2013 in Analytical Chemistry
Verified
Journal Article
Closed access
FDFrédérique Deiss
Frédérique Deiss
AMAaron Mazzeo
Aaron Mazzeo
EHEstrella Hong
Estrella Hong
DIDonald E. Ingber
Donald E. Ingber
RDRatmir Derda
Ratmir Derda
GWGeorge M. Whitesides
George M. Whitesides

19 February 2016 in Chemical Science
Verified
Journal Article
Open access
PDF file
SKS. Kalhor-Monfared
S. Kalhor-Monfared
MJM. R. Jafari
M. R. Jafari
JPJ. T. Patterson
J. T. Patterson
PKP. I. Kitov
P. I. Kitov
JDJ. J. Dwyer
J. J. Dwyer
RDRatmir Derda
Ratmir Derda
In this manuscript, we describe modification of Cys-residues in peptides and proteins in aqueous solvents via aromatic nucleophilic substitution (SNAr) with perfluoroarenes (fAr).

31 October 2011 in ACS Chemical Biology
Verified
Journal Article
Closed access
SNSimon Ng
Simon Ng
MJMohammad R. Jafari
Mohammad R. Jafari
RDRatmir Derda
Ratmir Derda

20 December 2010 in Journal of Biological Engineering
Verified
Journal Article
Open access
PDF file
JNJulie E Norville
Julie E Norville
RDRatmir Derda
Ratmir Derda
SGSaurabh Gupta
Saurabh Gupta
KDKelly A Drinkwater
Kelly A Drinkwater
ABAngela M Belcher
Angela M Belcher
TKThomas F Knight
Thomas F Knight
BioBrick standard biological parts are designed to make biological systems easier to engineer (e.g. assemble, manipulate, and modify). There are over 5,000 parts available in the Registry of Standard Biological Parts that can be easily assembled into genetic circuits using a standard assembly technique. The standardization of the assembly technique has allowed for wide distribution to a large number of users -- the parts are reusable and interchangeable during the assembly process. The standard assembly process, however, has some limitations. In particular it does not allow for modification of already assembled biological circuits, addition of protein tags to pre-existing BioBrick parts, or addition of non-BioBrick parts to assemblies.